|Publisher||University of Exeter|
|Commissioning body||National Institute for Health and Care Excellence (NICE)|
|Number of pages||214|
|Publication status||Published - 2011|
Hoyle, M., Crathorne, L., Peters, J., Jones-Hughes , T., Cooper, C., Napier, M., ... Hyde, C. (2011). The effectiveness and cost effectiveness of cetuximab (mono- or combination chemotherapy), bevacizumab (combination with non-oxaliplatin chemotherapy) and panitumumab (monotherapy) for the treatment of metastatic colorectal cancer after first-line chemotherapy (review of technology appraisal 150 and part review of technology appraisal 118): a systematic review and economic model. University of Exeter.